2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

MeSH terms

• Antihypertensive Agents / therapeutic use
• Aortic Valve Insufficiency / diagnosis
• Aortic Valve Insufficiency / therapy
• Aortic Valve Stenosis / diagnosis
• Aortic Valve Stenosis / therapy
• Cardiac Catheterization*
• Cardiology / standards*
• Cardiovascular Agents / therapeutic use*
• Disease Management
• Echocardiography
• Evidence-Based Medicine / standards
• Exercise Test* / adverse effects
• Exercise Test* / methods
• Heart Defects, Congenital / complications
• Heart Valve Diseases / complications
• Heart Valve Diseases / diagnosis*
• Heart Valve Diseases / etiology
• Heart Valve Diseases / physiopathology
• Heart Valve Diseases / therapy*
• Heart Valve Prosthesis Implantation* / standards
• Hemodynamics
• Humans
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
• Mitral Valve Insufficiency / diagnosis
• Mitral Valve Insufficiency / therapy
• Mitral Valve Stenosis / diagnosis
• Mitral Valve Stenosis / therapy
• Patient Care Team
• Pharyngitis / complications
• Pharyngitis / microbiology
• Referral and Consultation
• Rheumatic Fever / etiology
• Rheumatic Fever / prevention & control*
• Secondary Prevention / methods
• Severity of Illness Index
• Streptococcal Infections / complications
• United States
• Vasodilator Agents / therapeutic use
• Ventricular Dysfunction, Left / diagnosis
• Ventricular Dysfunction, Left / etiology
• Ventricular Dysfunction, Left / therapy